Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Nodule 1Insulin Resistance 1Diabetes Mellitus, Type 2 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Sitagliptin Phosphate × Clear all
NCT04298684 2020-09-11

METNODTHYR

Centre Hospitalier Universitaire de la Guadeloupe

Phase 4 Unknown
90 enrolled
Head & Neck

Diabetes Mellitus, Type 2, Insulin Resistance, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡